AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Onconic Therapeutics

₩14630 -$5230.00 (-26.33%)
KOE · 14 Sep 2026 06:30 UTC
Previous Close
₩14950
Day Range
₩14450₩14990
Year Range
₩8700₩28900
Market Cap
161.91B
AVG Volume
590.38K
Trailing/Forward PE
26.92/3.01
PEG ratio
0.33
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
KOSDAQKR
Revenue (KRW)
010B20B30B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Revenue (KRW) by quarter
PeriodRevenue (KRW)
26 Q224.4B
26 Q122.98B
25 Q415.58B
25 Q319.21B
25 Q29.43B
25 Q19.17B
24 Q48.84B
24 Q31.99B
24 Q22.7B
24 Q11.32B
Net Income (KRW)
-10B-5B05B10B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Net Income (KRW) by quarter
PeriodNet Income (KRW)
26 Q23.77B
26 Q16.42B
25 Q44.66B
25 Q39.4B
25 Q2-155.74M
25 Q11.88B
24 Q45.63B
24 Q3-2.78B
24 Q2-7.89B
24 Q1-3.05B
Operating Income (KRW)
-5B05B10B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Operating Income (KRW) by quarter
PeriodOperating Income (KRW)
26 Q22.79B
26 Q14.59B
25 Q41.61B
25 Q38.32B
25 Q21.11B
25 Q11.58B
24 Q41.37B
24 Q3-2.35B
24 Q2-786.9M
24 Q1-3.03B
EBITDA (KRW)
-10B-5B05B10B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ EBITDA (KRW) by quarter
PeriodEBITDA (KRW)
26 Q22.94B
26 Q14.73B
25 Q41.75B
25 Q39.54B
25 Q2-19.84M
25 Q12.01B
24 Q43.48B
24 Q3-2.65B
24 Q2-7.34B
24 Q1-2.31B
Cash Flows (KRW)
-5B05B10B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Cash Flows (KRW) by quarter
PeriodCash Flows (KRW)
26 Q23.59B
26 Q13.38B
25 Q41.77B
25 Q37.75B
25 Q2343M
25 Q11.23B
24 Q4-2.24B
24 Q3-3.57B
24 Q225.09M
24 Q1-2.2B
EPS (KRW)
-1000-5000500100024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ EPS (KRW) by quarter
PeriodEPS (KRW)
26 Q282.2
26 Q1138.91
25 Q4104.72
25 Q3212.4
25 Q2-14
25 Q143.25
24 Q4592.25
24 Q3-302
24 Q2-968
24 Q1-528
Expenses (KRW)
05B10B15B20BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Expenses (KRW) by quarter
PeriodExpenses (KRW)
26 Q27.6B
26 Q117.87B
25 Q413.49B
25 Q312.87B
25 Q27.99B
25 Q16.38B
24 Q46.74B
24 Q33.75B
24 Q23B
24 Q13.72B
Cash & Debt (KRW)
020B40B60B80BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Cash & Debt (KRW) by quarter
PeriodCash & Debt (KRW)
26 Q262.62B
26 Q157.31B
25 Q452.74B
25 Q353.59B
25 Q245.19B
25 Q144.48B
24 Q443B
24 Q324.52B
24 Q228.58B
24 Q10
Debt ratios
-20-1001024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Debt ratios by quarter
PeriodDebt ratios
26 Q2-3.29
26 Q1-3.58
25 Q4-3.96
25 Q3-3.56
25 Q2-16.01
25 Q19.79
24 Q44.84
24 Q31.35
24 Q21.53
24 Q1-0
Margins
0%25%50%75%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Margins by quarter
PeriodMargins
26 Q242.37%
26 Q140.56%
25 Q437.55%
25 Q3100%
25 Q2100%
25 Q1100%
24 Q4100%
24 Q3100%
24 Q2100%
24 Q1100%
Return on Capital
-40%-20%0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Return on Capital by quarter
PeriodReturn on Capital
26 Q24.39%
26 Q18.08%
25 Q46.47%
25 Q313.65%
25 Q2-0.26%
25 Q13.22%
24 Q410.05%
24 Q3-9.14%
24 Q2-23.99%
24 Q151.79%
Shares Outstanding
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Shares Outstanding by quarter
PeriodShares Outstanding
26 Q245.33M
26 Q144.87M
25 Q444.49M
25 Q344.25M
25 Q211.12M
25 Q110.83M
24 Q49.5M
24 Q39.2M
24 Q28.15M
24 Q15.78M
Book Value Per Share (KRW)
-2000020004000600024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Book Value Per Share (KRW) by quarter
PeriodBook Value Per Share (KRW)
26 Q21892.14
26 Q11772.31
25 Q41619.23
25 Q31556.77
25 Q25302.22
25 Q15387.99
24 Q45894.24
24 Q33302.87
24 Q24034.19
24 Q1-1019.49
Total Assets (KRW)
025B50B75B100B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
476060.KQ Total Assets (KRW) by quarter
PeriodTotal Assets (KRW)
26 Q292.98B
26 Q187.59B
25 Q475.71B
25 Q373.88B
25 Q263.62B
25 Q162.57B
24 Q460.91B
24 Q333.84B
24 Q235.75B
24 Q10
PE Ratio
20406080med 46.48Oct 25Dec 25Jan 26Mar 26May 26Jul 26Sep 26
476060.KQ PE Ratio by quarter
PeriodPE Ratio
Sep 2633
Sep 2636.29
Aug 2632.6
Aug 2632.05
Aug 2632.69
Aug 2631.01
Jul 2623.88
Jul 2624.15
Jul 2632.01
Jul 2625.83
Jul 2627.9
Jun 2635.37
Jun 2644.37
Jun 2644.28
Jun 2645.8
May 2653.7
May 2658.91
May 2655.05
May 2657.5
Apr 2659.9
Apr 2663.28
Apr 2668.21
Apr 2659.62
Apr 2657.22
Mar 2660.87
Mar 2663.25
Mar 2669.19
Mar 2652.82
Feb 2662.06
Feb 2649.89
Feb 2648.41
Feb 2643.73
Jan 2648.52
Jan 2649.44
Jan 2652.95
Jan 2658.76
Jan 2652.45
Dec 2553.05
Dec 2546.04
Dec 2546.92
Dec 2542.05
Nov 2550.49
Nov 2541.71
Nov 2535.19
Nov 2533.53
Oct 2541.71
Oct 2545.46
Oct 2544.7
Oct 2551.47
Oct 2539.66
Free Cash Flow Yield
-7.5%-5%-2.5%0%2.5%5%med -1.75%Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
476060.KQ Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 261.97%
Sep 261.8%
Aug 262%
Aug 262.03%
Aug 261.99%
Aug 262.1%
Jul 262.73%
Jul 262.7%
Jul 262.04%
Jul 262.52%
Jul 262.34%
Jun 261.99%
Jun 261.58%
Jun 261.59%
Jun 261.53%
May 261.31%
May 261.19%
May 261.28%
May 261.22%
Apr 261.17%
Apr 261.11%
Apr 261.03%
Apr 261.18%
Apr 261.23%
Mar 260.69%
Mar 260.67%
Mar 260.61%
Mar 260.8%
Feb 260.68%
Feb 260.85%
Feb 260.87%
Feb 260.97%
Jan 260.87%
Jan 260.86%
Jan 260.8%
Jan 260.72%
Jan 260.81%
Dec 25-1.75%
Dec 25-2.01%
Dec 25-1.98%
Dec 25-2.21%
Nov 25-1.84%
Nov 25-2.22%
Nov 25-2.64%
Nov 25-2.77%
Oct 25-2.22%
Oct 25-2.04%
Oct 25-2.07%
Oct 25-1.8%
Oct 25-2.34%
Sep 25-3.19%
Sep 25-3.73%
Sep 25-1.55%
Sep 25-1.26%
Aug 25-1.58%
Aug 25-1.79%
Aug 25-1.7%
Aug 25-1.67%
Aug 25-1.78%
Jul 25-1.61%
Jul 25-1.51%
Jul 25-1.49%
Jul 25-1.9%
Jun 25-3.95%
Jun 25-3.59%
Jun 25-3.4%
Jun 25-3.98%
May 25-3.82%
May 25-4.18%
May 25-3.99%
May 25-3.99%
May 25-3.73%
Apr 25-3.44%
Apr 25-3.54%
Apr 25-3.48%
Apr 25-3.43%
Mar 25-3.81%
Mar 25-4.79%
Mar 25-5.49%
Mar 25-5.64%
Feb 25-5.25%
Feb 25-4.96%
Feb 25-4.97%
Feb 25-5.06%
Jan 25-5.24%
Jan 25-5.28%
Jan 25-5.03%
Jan 25-4.18%
Jan 25-4.85%
Dec 24-6.75%
Dec 24-4.95%
Price to Sales
0102030med 14.09Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
476060.KQ Price to Sales by quarter
PeriodPrice to Sales
Sep 269.98
Sep 2610.98
Aug 269.86
Aug 269.69
Aug 269.89
Aug 269.38
Jul 267.22
Jul 267.3
Jul 269.68
Jul 267.81
Jul 268.44
Jun 2610.46
Jun 2613.12
Jun 2613.09
Jun 2613.54
May 2615.87
May 2617.42
May 2616.27
May 2617
Apr 2617.71
Apr 2618.71
Apr 2620.17
Apr 2617.62
Apr 2616.92
Mar 2621.86
Mar 2622.72
Mar 2624.85
Mar 2618.97
Feb 2622.29
Feb 2617.92
Feb 2617.38
Feb 2615.71
Jan 2617.42
Jan 2617.75
Jan 2619.02
Jan 2621.1
Jan 2618.84
Dec 258.24
Dec 257.15
Dec 257.29
Dec 256.53
Nov 257.84
Nov 256.48
Nov 255.47
Nov 255.21
Oct 256.48
Oct 257.06
Oct 256.94
Oct 258
Oct 256.16
Sep 256.3
Sep 255.38
Sep 2512.98
Sep 2515.92
Aug 2512.73
Aug 2511.2
Aug 2511.82
Aug 2512.06
Aug 2511.32
Jul 2512.44
Jul 2513.32
Jul 2513.49
Jul 2510.55
Jun 2513.61
Jun 2514.99
Jun 2515.82
Jun 2513.51
May 2514.09
May 2512.87
May 2513.48
May 2513.48
May 2514.41
Apr 2515.63
Apr 2515.21
Apr 2515.47
Apr 2515.69
Mar 2524.83
Mar 2519.77
Mar 2517.26
Mar 2516.8
Feb 2518.06
Feb 2519.11
Feb 2519.04
Feb 2518.72
Jan 2518.08
Jan 2517.93
Jan 2518.83
Jan 2522.67
Jan 2519.51
Dec 2420.91
Dec 2428.49
EV/EBITDA
20406080med 52.3Oct 25Dec 25Jan 26Mar 26May 26Jul 26Sep 26
476060.KQ EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2638.36
Sep 2642.54
Aug 2637.86
Aug 2637.16
Aug 2637.97
Aug 2635.84
Jul 2626.78
Jul 2627.11
Jul 2637.1
Jul 2629.25
Jul 2631.88
Jun 2638.1
Jun 2648.79
Jun 2648.69
Jun 2650.5
May 2659.88
May 2666.08
May 2661.49
May 2664.41
Apr 2667.26
Apr 2671.28
Apr 2677.15
Apr 2666.92
Apr 2664.07
Mar 2664.43
Mar 2667.08
Mar 2673.72
Mar 2655.43
Feb 2665.75
Feb 2652.16
Feb 2650.5
Feb 2645.28
Jan 2650.62
Jan 2651.65
Jan 2655.58
Jan 2662.07
Jan 2655.02
Dec 2570.34
Dec 2558.94
Dec 2560.36
Dec 2552.44
Nov 2566.19
Nov 2551.88
Nov 2541.27
Nov 2538.57
Oct 2551.88
Oct 2557.99
Oct 2556.76
Oct 2567.77
Oct 2548.56
Price/Operating Cashflow
050100150200med 79.65Jan 26Feb 26Mar 26May 26Jun 26Jul 26Sep 26
476060.KQ Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2649.37
Sep 2654.29
Aug 2648.77
Aug 2647.95
Aug 2648.9
Aug 2646.4
Jul 2635.73
Jul 2636.13
Jul 2647.88
Jul 2638.64
Jul 2641.74
Jun 2649
Jun 2661.45
Jun 2661.34
Jun 2663.45
May 2674.38
May 2681.6
May 2676.25
May 2679.65
Apr 2682.97
Apr 2687.65
Apr 2694.48
Apr 2682.58
Apr 2679.26
Mar 26139.84
Mar 26145.3
Mar 26158.95
Mar 26121.33
Feb 26142.57
Feb 26114.6
Feb 26111.2
Feb 26100.46
Jan 26111.44
Jan 26113.57
Jan 26121.64
Jan 26134.98
Jan 26120.48
Price to Book
05101520med 4.83Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
476060.KQ Price to Book by quarter
PeriodPrice to Book
Sep 268.44
Sep 269.28
Aug 268.33
Aug 268.19
Aug 268.36
Aug 267.93
Jul 266.11
Jul 266.17
Jul 268.18
Jul 266.6
Jul 267.13
Jun 267.75
Jun 269.72
Jun 269.7
Jun 2610.04
May 2611.76
May 2612.91
May 2612.06
May 2612.6
Apr 2613.12
Apr 2613.86
Apr 2614.95
Apr 2613.06
Apr 2612.54
Mar 2614.81
Mar 2615.38
Mar 2616.83
Mar 2612.85
Feb 2615.1
Feb 2612.13
Feb 2611.77
Feb 2610.64
Jan 2611.8
Jan 2612.02
Jan 2612.88
Jan 2614.29
Jan 2612.76
Dec 254.11
Dec 253.57
Dec 253.64
Dec 253.26
Nov 253.91
Nov 253.23
Nov 252.73
Nov 252.6
Oct 253.23
Oct 253.52
Oct 253.46
Oct 253.99
Oct 253.07
Sep 252.45
Sep 252.09
Sep 255.05
Sep 256.19
Aug 254.95
Aug 254.35
Aug 254.59
Aug 254.69
Aug 254.4
Jul 254.83
Jul 255.18
Jul 255.24
Jul 254.1
Jun 253.61
Jun 253.97
Jun 254.19
Jun 253.58
May 253.73
May 253.41
May 253.57
May 253.57
May 253.82
Apr 254.14
Apr 254.03
Apr 254.1
Apr 254.16
Mar 256.05
Mar 254.82
Mar 254.21
Mar 254.09
Feb 254.4
Feb 254.66
Feb 254.64
Feb 254.56
Jan 254.41
Jan 254.37
Jan 254.59
Jan 255.52
Jan 254.75
Dec 243.89
Dec 245.3
Onconic Therapeutics
476060.KQ
Stockpicker

Video analysis: 476060.KQ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.